FTO and breast cancer: Tan reported that FTO was highly expressed in hormone receptor (HR)-negative and HER2-positive BC patients, based on the immunohistochemical staining of specimens from 79 infiltrating ductal breast cancer (IDBC) patients (Tan et al., 2015).